Purchase Order 19PCRD26K4471
- Not listed
- The U.S. Department of State's Bureau of Administration awarded a $12,173.36 firm fixed-price purchase order to Biofire Defense LLC on July 22, 2025, for medical supplies with an ultimate completion date of August 8, 2025. This contract, with no set-aside designation, is issued against the Department of State's existing $4.5 million Blanket Purchase Agreement with Biofire Defense for laboratory testing supplies. The work will be performed in Salt Lake City, Utah, where Biofire Defense is...
- The U.S. Department of State's Bureau of African Affairs awarded Biofire Defense LLC a $12.75M purchase order for laboratory supplies required in December 2025, with an ultimate completion date of January 30, 2026. This firm fixed-price contract, which carries no set-aside designation, was awarded on January 20, 2026, and will be performed at Biofire Defense's facility in Salt Lake City, Utah. The award supports the Department's medical testing requirements, procuring specialized laboratory...
- Biofire Defense LLC, a Salt Lake City-based manufacturer of molecular diagnostic technologies, was awarded a $12,746.23 firm fixed-price purchase order by the U.S. Department of State's Bureau of Administration on January 28, 2026, with completion targeted for February 26, 2026. The contract, which carries no set-aside designation, procures medical supplies to support the Department's diagnostic and testing requirements. This award is issued under Biofire Defense's $4.5 million single-award...
- The U.S. Department of State's Bureau of Administration awarded a $12,173.36 firm fixed-price purchase order to Biofire Defense LLC on July 7, 2025, for the procurement of medical supplies with an ultimate completion date of August 2, 2025. The contract, which carries no set-aside designation, represents a delivery order under the Department of State's $4.5 million Blanket Purchase Agreement with Biofire Defense for laboratory testing supplies. Biofire Defense, a Salt Lake City-based...
- Biofire Defense LLC was awarded a firm fixed-price purchase order valued at $11,150.69 for medical supplies by the U.S. Department of State's Bureau of Administration, with an ultimate completion date of March 7, 2026. This contract award represents a direct order draw against Biofire Defense's $4.5 million single-award Blanket Purchase Agreement with the State Department's Bureau of Administration, which was established in March 2025 and extends through March 2027. The blanket purchase...
- The Department of State's Bureau of Administration awarded a BPA (Blanket Purchase Agreement) call order to Biofire Defense LLC on September 15, 2025, for biofire lab test kits and products. This contract, valued at $7,733.66 with a firm fixed-price structure, is designated as a Total Small Business set-aside and is scheduled for completion by October 27, 2025. The order represents a call against Biofire Defense's existing $4.5 million BPA with the State Department for laboratory testing...
- Biofire Defense LLC, a Salt Lake City-based manufacturer of molecular diagnostic technologies, was awarded a $16,262.03 firm fixed-price Blanket Purchase Agreement (BPA) call order by the Department of State's Bureau of Administration on December 19, 2025. This Total Small Business set-aside contract, with an ultimate completion date of January 27, 2026, covers Biofire lab test kits and products. The award leverages Biofire Defense's existing $4.5 million BPA with the Department of State for...
- Biofire Defense LLC, a Salt Lake City-based manufacturer of molecular diagnostic technologies, was awarded a $4,439.70 firm fixed-price call order under a Blanket Purchase Agreement with the U.S. Department of State's Bureau of Administration for Biofire Lab Test Kits and Products. This contract is designated as a Total Small Business set-aside and represents a delivery order against the existing $4.5 million BPA that covers specialized laboratory testing supplies, including FilmArray...
- This is a $12,395.20 firm fixed-price purchase order awarded by the U.S. Department of State's Bureau of Administration to Biofire Defense LLC, a for-profit limited liability company based in Salt Lake City, Utah. The contract is for the provision of medical supplies, with no set-aside designation. Biofire Defense is a manufacturer of biological agent identification products and advanced diagnostic solutions, including the Biofire FilmArray and RAZOR Mk II systems, which are designed for rapid...
- Biofire Defense LLC, a Salt Lake City-based manufacturer of molecular diagnostic technologies, was awarded a $6,394.49 firm fixed-price call order under a Blanket Purchase Agreement (BPA) with the Department of State's Bureau of Administration for Biofire Lab Test Kits and Products. The award, issued on December 22, 2025, carries a total small business set-aside designation and is designated for completion by January 30, 2026. This call order represents a task against the larger $4.5 million BPA...
On February 6, 2026, the U.S. Department of State's Bureau of Administration awarded a $11,723.56 firm fixed-price purchase order to Biofire Defense LLC for medical supplies. The contract, with a completion date of March 7, 2026, supports the Department's laboratory testing requirements, likely procuring specialized diagnostic supplies including FilmArray test panels and related consumables. This award carries no set-aside designation and reflects Biofire Defense's established position as a critical federal vendor for molecular diagnostic technologies and biological agent identification products. The work will be performed in Salt Lake City, Utah, where Biofire Defense is headquartered. This purchase order is issued under the Department of State's $4.5 million single-award Blanket Purchase Agreement with Biofire Defense, established in March 2025 through March 2027, which provides a pre-negotiated vehicle for acquiring specialized laboratory testing supplies to support the Department's medical testing operations at embassies worldwide. Biofire Defense, a Salt Lake City-based manufacturer registered as a federal contractor since 2001, specializes in rapid pathogen identification systems and has developed an extensive federal contract portfolio serving the Department of Defense, National Institutes of Health, and Defense Health Agency, among other agencies. The company's diagnostic product portfolio, including the FilmArray and RAZOR Mk II systems, directly supports government biodefense and public health preparedness missions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 2/6/26 |